Mutations leading to the aberrant function of the RB tumor suppressor protein (pRB) have been found not only in retinoblastoma cancer and cell lines but also in various other tumors, such as osteosarcoma, adenocarcinoma, small cell lung cancer, breast cancer, and prostate cancer (13). This evidence concerns the gene RB1 and small cell lung carcinoma.